Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Italian Observational Study on Real-Life Use of Venetoclax in Acute Myeloid Leukemia (AVALON study): Results of Interim Analysis on Relapsed/Refractory Patients

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-143082

Published: 2020

Journal Articles

B-ALL/NHL 2002 GMALL Protocol As First-Line Treatment in Patients with Double-Hit Lymphoma: Favorable Results in18 Consecutive Patients from Two Italian Institutions

Safaa M. Ramadan, PhD MD, Alessandro Cignetti, MD PhD, Simona Sammassimo, MD, Enrico Derenzini, MD PhD, Giusy Ceparano, MD, Tommaso Radice, MD, Federica Gigli, MD, Stefano Fiori, MD, Valentina Tabanelli, MD, Martina Milani, Emanuela Omodeo Sale', Sara Gandini, PhD, Daniela Gottardi, MD, Giuseppe Saglio, MD, Stefano Pileri, MD, Corrado Tarella, MD

Blood (2019) 134 (Supplement_1): 1631.

https://doi.org/10.1182/blood-2019-128794

Published: 2019

Journal Articles

Next Generation Sequencing and Microrna Assay in a Cohort of Patients Affected By Myelodysplastic Syndromes. an Analysis of Clinical and Genotypic Features

Daniele Avenoso, MD, Margherita Squillario, Annalisa Barla, Alessandro Verri, Enrico Carminati, Clara Nurra, Elisabetta Todisco, MD PhD, Federica Gigli, MD, Giuliana Gregato, Claudia Poletti, Francesco Bertolini, MD PhD, Ghulam J. Mufti, MBBS, FRCP, FRCPath, DM, Mili Shah, FRCPath, Maurizio Miglino

Blood (2019) 134 (Supplement_1): 5414.

https://doi.org/10.1182/blood-2019-130153

Published: 2019

Journal Articles

Prognostic Value of End of Treatment FDG-PET Scan in T-Cell Lymphoma, a 20-Year Single Institution Study

Enrico Derenzini, MD PhD, Angela Gueli, MD, Safaa Ramadan, PhD MD, Anna Vanazzi, MD, Simona Sammassimo, MD, Federica Gigli, MD, Niccolo' Frungillo, MD, Riccardo Bruna, MD, Alberto Agazzi, MD, Alberto De Crescenzo, MD, Rocco Pastano, MD, Laura L Travaini, MD, Chiara Grana, MD, Laszlo Daniele, MD, William Arcese, Corrado Tarella, MD

Blood (2016) 128 (22): 3003.

https://doi.org/10.1182/blood.V128.22.3003.3003

Published: 2016

Journal Articles

Unmanipulated, G-CSF Mobilized Peripheral Blood Stem Cells As Graft Source for Non-Myeloablative Haploidentical Transplantation: Fast Engraftment, No Evidence of Graft Rejection, and Low Incidence of Graft-Versus-Host Disease

Rocco Pastano, MD, Giovanna Andreola, MD, Federica Gigli, MD, Simona Sammassimo, MD, Mara Negri, Liptrott Jayne Sarah, Corrado Tarella, MD

Blood (2015) 126 (23): 1924.

https://doi.org/10.1182/blood.V126.23.1924.1924

Published: 2015

Journal Articles

Rituximab and Chlorambucil as Front-Line Treatment in Untreated Follicular Lymphoma: a Combination with a Durable Response and Low Toxicity Profile.

Simona Bassi, MD, Luca Nassi, MD, Giancarlo Pruneri, MD, Simona Sammassimo, MD, Paola Bertazzoni, MD, Federica Gigli, MD, Anna Vanazzi, MD, Emilia Cocorocchio, MD, Patrizia Mancuso, Cristina Rabascio, Maria Teresa Lionetti, Daniele Laszlo, MD, Giovanni Martinelli, MD

Blood (2009) 114 (22): 3754.

https://doi.org/10.1182/blood.V114.22.3754.3754

Published: 2009

Journal Articles

Combined VBM Chemotherapy and Involved Field (IF) Radiotherapy in Early Stage Hodgkin’s Lymphoma (HL): A Single Centre Experience.

Emilia Cocorocchio, MD, Fedro A. Peccatori, MD, Federica Gigli, MD, Simona Bassi, MD, Luca Nassi, MD, Liliana Calabrese, DSc, Laura Travaini, MD, Gaia Piperno, MD, Lorenzo Preda, MD, Giancarlo Pruneri, MD, Sarah J. Liptrott, BN, Alessandra Alietti, MD, Giovanni Martinelli, MD

Blood (2007) 110 (11): 4463.

https://doi.org/10.1182/blood.V110.11.4463.4463

Published: 2007

Journal Articles

Continuous Immuno-Chemotherapy Followed by High Dose and Autologous Cell Transplantation May Improve the Event-Free-Survival in Mantle Cell Lymphoma Patients. Experience at the European Institute of Oncology in Milan.

Simona Bassi, MD, Alessandra Alietti, MD, Chiara Corsini, DSc, Federica Gigli, MD, Paola Bertazzoni, MD, Cristina Rabascio, DSc, Patrizia Mancuso, DSc, Emilia Cocorocchio, MD, Daniele Laszlo, MD, Giancarlo Pruneri, MD, Lorenzo Preda, MD, Sarah J. Liptrott, BN, Rosaria Cascio, PH, Francesco Bertolini, MD, Giovanni Martinelli, MD

Blood (2007) 110 (11): 5116.

https://doi.org/10.1182/blood.V110.11.5116.5116

Published: 2007

Journal Articles

Valganciclovir Is Safe and Effective as Pre-Emptive Treatment for CMV Infection in Allogeneic Hematopoietic Stem Cell Transplantation.

Rocco Pastano, MD, Federica Gigli, MD, Giovanna Andreola, MD, Liliana Calabrese, DM, Fedro Peccatori, MD, Giovanni Martinelli, MD

Blood (2006) 108 (11): 5300.

https://doi.org/10.1182/blood.V108.11.5300.5300

Published: 2006

Journal Articles

High Dose Chemotherapy with Autologous Stem Cell Support Is Effective in Resistant and Refractory Hodgkin Lymphoma. A Single Center Analysis.

Emilia Cocorocchio, MD, Fedro Peccatori, MD, Simona Bassi, MD, Federica Gigli, MD, Davide Radice, Giancarlo Pruneri, MD, Cristina Rabascio, Liliana Calabrese, Giovanni Martinelli, MD

Blood (2005) 106 (11): 5506.

https://doi.org/10.1182/blood.V106.11.5506.5506

Published: 2005

Journal Articles

Graft-Versus-Lymphoma Effect in Hodgkin’s Disease: A Possible Role in Maintaining a Disease Control.

Rocco Pastano, MD, Giovanna Andreola, MD, Federica Gigli, MD, Luca Saronni, Maria C. Cassatella, Fedro Peccatori, MD, Giovanni Martinelli, MD

Blood (2005) 106 (11): 5423.

https://doi.org/10.1182/blood.V106.11.5423.5423

Published: 2005

Journal Articles

Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation in Renal Cell Carcinoma: The EIO Experience.

Rocco Pastano, MD, Daniele Laszlo, MD, Giovanna Andreola, MD, Federica Gigli, MD, Cristina Rabascio, Valentina Raia, Manuela Cazzanti, Fedro Peccatori, MD, Giovanni Martinelli, MD

Blood (2005) 106 (11): 5424.

https://doi.org/10.1182/blood.V106.11.5424.5424

Published: 2005

Journal Articles

Tumor Control Achieved Despite Loss of Chimaerism in Renal Cell Carcinoma (RCC) Following Non-Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT): A Case Report.

Giovanna Andreola, MD, Federica Gigli, MD, Cristina Rabascio, Manuela Cazzanti, Fedro Peccatori, MD, Saverio Cinieri, MD, Rocco Pastano, MD, Giovanni Martinelli, MD

Blood (2005) 106 (11): 5401.

https://doi.org/10.1182/blood.V106.11.5401.5401

Published: 2005

NARROW

Italian Observational Study on Real-Life Use of Venetoclax in Acute Myeloid Leukemia (AVALON study): Results of Interim Analysis on Relapsed/Refractory Patients

B-ALL/NHL 2002 GMALL Protocol As First-Line Treatment in Patients with Double-Hit Lymphoma: Favorable Results in18 Consecutive Patients from Two Italian Institutions

Next Generation Sequencing and Microrna Assay in a Cohort of Patients Affected By Myelodysplastic Syndromes. an Analysis of Clinical and Genotypic Features

Prognostic Value of End of Treatment FDG-PET Scan in T-Cell Lymphoma, a 20-Year Single Institution Study

Unmanipulated, G-CSF Mobilized Peripheral Blood Stem Cells As Graft Source for Non-Myeloablative Haploidentical Transplantation: Fast Engraftment, No Evidence of Graft Rejection, and Low Incidence of Graft-Versus-Host Disease

Rituximab and Chlorambucil as Front-Line Treatment in Untreated Follicular Lymphoma: a Combination with a Durable Response and Low Toxicity Profile.

Combined VBM Chemotherapy and Involved Field (IF) Radiotherapy in Early Stage Hodgkin’s Lymphoma (HL): A Single Centre Experience.

Continuous Immuno-Chemotherapy Followed by High Dose and Autologous Cell Transplantation May Improve the Event-Free-Survival in Mantle Cell Lymphoma Patients. Experience at the European Institute of Oncology in Milan.

Valganciclovir Is Safe and Effective as Pre-Emptive Treatment for CMV Infection in Allogeneic Hematopoietic Stem Cell Transplantation.

High Dose Chemotherapy with Autologous Stem Cell Support Is Effective in Resistant and Refractory Hodgkin Lymphoma. A Single Center Analysis.

Graft-Versus-Lymphoma Effect in Hodgkin’s Disease: A Possible Role in Maintaining a Disease Control.

Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation in Renal Cell Carcinoma: The EIO Experience.

Tumor Control Achieved Despite Loss of Chimaerism in Renal Cell Carcinoma (RCC) Following Non-Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT): A Case Report.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only